Pharmacology

April 10, 2013

Arrhythmia drug unavailable in most countries: study

By Logan Lafferty Logan Lafferty

An inexpensive drug that can prevent some life-threatening heart rhythm problems is unavailable in most places, according to a new survey of doctors in 131 countries…Only about one in 10,000 people inherits Brugada syndrome and even fewer have symptoms, according to Dr. Michael Ackerman, who studies heart disorders at the Mayo Clinic in Rochester, Minnesota…”Quinidine […]

View full entry

Tags: arrhythmia, arrhythmia drug, Brugada syndrome, Dr. Michael Ackerman, Quinidine, Reuters, Reuters Health, unavailable


March 7, 2013

U.S. panel votes against calcitonin salmon bone drug

By Logan Lafferty Logan Lafferty

But other panelists said the drugs are an important option for patients who have bad reactions to newer drugs, including bisphosphonate drugs like Fosamax. “We have a whole lot of patients who can’t take the other drugs, and I think our patients would be in worse shape without this,” said Bart Clark, professor at the […]

View full entry

Tags: calcitonin, CTV, Dr. Bart Clark, Fosamax, Mayo Clinic College of Medicine


October 17, 2012

129 Minn. Clinics Got Potentially Tainted Drugs; Mayo Issues Statement

By Kelley Luckstein Kelley Luckstein

Minnesota Department of Health says 129 clinics in Minnesota got drug supplies from a pharmaceutical distributor that has been at the center of national concern about noninfectious meningitis cases. “It is not known at this time how many patients in Minnesota are affected,” the state agency said in a Tuesday afternoon alert…Mayo Clinic spokesman Bryan […]

View full entry

Tags: Bryan Anderson, Minnesota Department of Health, New England Compounding Center, noninfectious meningitis, Post Bulletin, tainted drugs


October 11, 2012

Pricey Soliris Performs in Another Rare Disease

By Kelley Luckstein Kelley Luckstein

Alexion’s ($ALXN) Soliris is arguably the most expensive drug in the world. The rare-disease therapy fights two life-threatening diseases–and it costs up to $400,000 per year, depending upon the patient. And if the company has its way, the drug may be targeted at another group of patients…Patients with NMO are progressively disabled by each attack. […]

View full entry

Tags: Alexion, FiercePharma, Sean J. Pittock, Soliris


July 26, 2012

Group Asks FDA to Provide Clearer Painkiller Guidelines

By Mystery User

A group of pain experts and health officials are asking the Food and Drug Administration to provide clearer guidance to physicians on how to use extended-release painkillers and to limit claims pharmaceutical companies can make about the high-dosage medications. If approved, drug companies would be blocked from marketing their powerful painkillers as remedies for more […]

View full entry

Tags: citizen's petition, extended-release painkillers, FDA, Wall Street Journal


July 26, 2012

Mayo Clinic in the News Weekly Highlights

By Mystery User

July 26, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Kelley Luckstein Public Affairs Associate Guest Editor […]

View full entry

Tags: Alzheimer's Treatment, Associated Press, Dartmouth-Hitchcock Medical Center, Dr. David Hayes, Dr. Michael Joyner, Dr. Ron Petersen, Edith Perez, heat-related medical problems, Mayo Clinic Comprehensive Cancer Center, Pfizer, Post Bulletin, Reader's Digest Canada


July 23, 2012

Unrelenting Heat Can Wither Your Meds, Too

By Mystery User

This has been a difficult summer for Aylssa McDermott. The Maplewood 12-year-old, who wears an insulin pump for diabetes, has landed in the emergency room three times after softball tournaments in which hot, humid air combined with her body heat to destroy her medication…At the Mayo Clinic emergency room in Rochester, Dr. Torrey Laack sees […]

View full entry

Tags: Dr. Torrey Laack, heat, medications, Star Tribune


July 10, 2012

Fake Avastin shows very little protects drug supply

By Mystery User

As drug counterfeiters step up their sales of bogus medicines, global health regulators have few protections in place to prevent them from reaching patients, and new laws aimed at addressing the problem could be years away…Larger hospitals are likely to have more quality controls in place than individual clinics, but there are still concerns. The […]

View full entry

Tags: Cardinal Health, counterfeit, Robert Wolf


June 22, 2012

Blood Pressure Drug Olmesartan Linked to Celiac Disease Side Effects in a Handful of Patients

By Mystery User

A drug used for treating high blood pressure has been linked with a number of severe gastrointestinal side effects, according to a report from the Mayo Clinic…”We thought these cases were celiac diseases initially because their biopsies showed features very like celiac disease, such as inflammation,” said Dr. Joseph Murray, the Mayo Clinic gastroenterologist treating […]

View full entry

Tags: ABC News, celiac diseases, Dr. Joseph Murray, gastrointestinal side effects, high blood pressure


June 19, 2012

FDA Proposal Gives Pharmacists Too Much Power, Doctors Argue

By Mystery User

Physicians are concerned regarding a recent government proposal to create a new class of drugs that would fall somewhere between those that need a doctor’s prescription, and those that can be bought over the counter… In an AMA committee meeting yesterday, Dr. Robert Orford, an assistant professor of medicine at the Mayo Clinic in Arizona, […]

View full entry

Tags: Dr. Robert Orford, government proposal, MyHealthNewsDaily, prescription drug


Contact Us · Privacy Policy